Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in Advanced Retroperitoneal Sarcoma
NCT02247544Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Mar 2014
- Primary completion
- Mar 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in leiomyosarcoma (LMS), Liposarcoma, sponsored by Italian Sarcoma Group. Started Mar 2014; status: completed.
02
Drugs
trabectedin
03
Conditions
leiomyosarcoma (LMS)Liposarcoma
Beyond the preview
Go deeper on NCT02247544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247544.